Overview

Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Status:
Completed
Trial end date:
2019-09-26
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies pomegranate-extract pill in preventing tumor growth in patients with prostate cancer that is limited to a certain part of the body (localized), who have chosen observation as their treatment plan. The use of pomegranate-extract pill may slow disease progression in patients with localized prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI)